PortfoliosLab logo
RDY vs. HLN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between RDY and HLN is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

RDY vs. HLN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dr. Reddy's Laboratories Limited (RDY) and Haleon plc (HLN). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

RDY:

0.40

HLN:

1.40

Sortino Ratio

RDY:

0.69

HLN:

2.05

Omega Ratio

RDY:

1.09

HLN:

1.29

Calmar Ratio

RDY:

0.35

HLN:

2.01

Martin Ratio

RDY:

0.71

HLN:

4.80

Ulcer Index

RDY:

13.10%

HLN:

6.57%

Daily Std Dev

RDY:

24.29%

HLN:

20.83%

Max Drawdown

RDY:

-58.55%

HLN:

-24.83%

Current Drawdown

RDY:

-14.56%

HLN:

-0.84%

Fundamentals

Market Cap

RDY:

$11.82B

HLN:

$47.02B

EPS

RDY:

$0.80

HLN:

$0.41

PE Ratio

RDY:

17.68

HLN:

25.37

PEG Ratio

RDY:

4.51

HLN:

3.15

PS Ratio

RDY:

0.04

HLN:

4.19

PB Ratio

RDY:

2.98

HLN:

2.20

Total Revenue (TTM)

RDY:

$240.48B

HLN:

$8.31B

Gross Profit (TTM)

RDY:

$143.17B

HLN:

$5.20B

EBITDA (TTM)

RDY:

$69.94B

HLN:

$1.73B

Returns By Period

In the year-to-date period, RDY achieves a -8.87% return, which is significantly lower than HLN's 13.12% return.


RDY

YTD

-8.87%

1M

8.03%

6M

1.05%

1Y

9.71%

5Y*

11.16%

10Y*

4.74%

HLN

YTD

13.12%

1M

6.64%

6M

15.92%

1Y

29.02%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RDY vs. HLN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RDY
The Risk-Adjusted Performance Rank of RDY is 6161
Overall Rank
The Sharpe Ratio Rank of RDY is 6868
Sharpe Ratio Rank
The Sortino Ratio Rank of RDY is 5656
Sortino Ratio Rank
The Omega Ratio Rank of RDY is 5555
Omega Ratio Rank
The Calmar Ratio Rank of RDY is 6767
Calmar Ratio Rank
The Martin Ratio Rank of RDY is 6060
Martin Ratio Rank

HLN
The Risk-Adjusted Performance Rank of HLN is 8888
Overall Rank
The Sharpe Ratio Rank of HLN is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of HLN is 8686
Sortino Ratio Rank
The Omega Ratio Rank of HLN is 8787
Omega Ratio Rank
The Calmar Ratio Rank of HLN is 9393
Calmar Ratio Rank
The Martin Ratio Rank of HLN is 8686
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RDY vs. HLN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Dr. Reddy's Laboratories Limited (RDY) and Haleon plc (HLN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current RDY Sharpe Ratio is 0.40, which is lower than the HLN Sharpe Ratio of 1.40. The chart below compares the historical Sharpe Ratios of RDY and HLN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

RDY vs. HLN - Dividend Comparison

RDY's dividend yield for the trailing twelve months is around 3.99%, more than HLN's 1.59% yield.


TTM20242023202220212020201920182017201620152014
RDY
Dr. Reddy's Laboratories Limited
3.99%3.64%1.39%1.48%0.52%0.47%0.70%0.77%0.84%0.66%0.67%0.58%
HLN
Haleon plc
1.59%1.66%1.26%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

RDY vs. HLN - Drawdown Comparison

The maximum RDY drawdown since its inception was -58.55%, which is greater than HLN's maximum drawdown of -24.83%. Use the drawdown chart below to compare losses from any high point for RDY and HLN. For additional features, visit the drawdowns tool.


Loading data...

Volatility

RDY vs. HLN - Volatility Comparison

Dr. Reddy's Laboratories Limited (RDY) has a higher volatility of 7.44% compared to Haleon plc (HLN) at 7.07%. This indicates that RDY's price experiences larger fluctuations and is considered to be riskier than HLN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

RDY vs. HLN - Financials Comparison

This section allows you to compare key financial metrics between Dr. Reddy's Laboratories Limited and Haleon plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00BAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
83.59B
2.76B
(RDY) Total Revenue
(HLN) Total Revenue
Values in USD except per share items

RDY vs. HLN - Profitability Comparison

The chart below illustrates the profitability comparison between Dr. Reddy's Laboratories Limited and Haleon plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%55.0%60.0%65.0%70.0%75.0%80.0%85.0%AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
58.7%
59.9%
(RDY) Gross Margin
(HLN) Gross Margin
RDY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Dr. Reddy's Laboratories Limited reported a gross profit of 49.05B and revenue of 83.59B. Therefore, the gross margin over that period was 58.7%.

HLN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Haleon plc reported a gross profit of 1.65B and revenue of 2.76B. Therefore, the gross margin over that period was 59.9%.

RDY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Dr. Reddy's Laboratories Limited reported an operating income of 18.72B and revenue of 83.59B, resulting in an operating margin of 22.4%.

HLN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Haleon plc reported an operating income of 350.00M and revenue of 2.76B, resulting in an operating margin of 12.7%.

RDY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Dr. Reddy's Laboratories Limited reported a net income of 14.13B and revenue of 83.59B, resulting in a net margin of 16.9%.

HLN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Haleon plc reported a net income of 231.00M and revenue of 2.76B, resulting in a net margin of 8.4%.